Myomo (MYO) Amortizatization of Intangibles (2016 - 2025)
Myomo's (MYO) quarterly Amortizatization of Intangibles came in at $187779.0 in Q3 2025, up 158.88% on a YoY basis from $72535.0 in Q3 2024, and down 20.98% quarter-over-quarter from $237649.0 in Q2 2025.
Powered by 
Analysis
Myomo (MYO) Amortizatization of Intangibles (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Amortizatization of Intangibles for 7 consecutive years, with $187779.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Amortizatization of Intangibles rose 158.88% year-over-year to $187779.0; the trailing twelve-month figure through Sep 2025 stood at $1.1 million (up 337.44% YoY), and the FY2024 full-year result was $571061.0, up 61.6% from the prior year.
- Amortizatization of Intangibles declined to $187779.0 in Q3 2025 per MYO's latest filing, from $237649.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $374469.0 in Q4 2024 and bottomed at $27594.0 in Q2 2021.
- Historically, Amortizatization of Intangibles has averaged $114663.7 across 5 years, with a median of $85984.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles sank 45.62% in 2023, then soared 615.7% in 2024.
- Over 5 years, Amortizatization of Intangibles stood at $63439.0 in 2021, then jumped by 51.67% to $96217.0 in 2022, then tumbled by 45.62% to $52322.0 in 2023, then jumped by 615.7% to $374469.0 in 2024, then tumbled by 49.85% to $187779.0 in 2025.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $187779.0, $237649.0, and $288951.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 187,779.00 |
| Jun 30, 2025 | 237,649.00 |
| Mar 31, 2025 | 288,951.00 |
| Dec 31, 2024 | 374,469.00 |
| Sep 30, 2024 | 72,535.00 |
| Jun 30, 2024 | 65,399.00 |
| Mar 31, 2024 | 58,658.00 |
| Dec 31, 2023 | 52,322.00 |
| Sep 30, 2023 | 91,428.00 |
| Jun 30, 2023 | 107,796.00 |
| Mar 31, 2023 | 101,829.00 |
| Dec 31, 2022 | 96,217.00 |
| Sep 30, 2022 | 90,973.00 |
| Jun 30, 2022 | 85,984.00 |
| Mar 31, 2022 | 76,654.00 |
| Dec 31, 2021 | 63,439.00 |
| Sep 30, 2021 | 59,876.00 |
| Jun 30, 2021 | 27,594.00 |
| Mar 31, 2021 | 39,059.00 |
| Jun 30, 2017 | 15,552.00 |